Detected ·
Kurma Partners
——
Kurma Partners, a member of Eurazeo Group, announces the final closing of its new Biofund IV for €215 million. The fund has already invested in 11 biotech companies and targets around 20 companies, focusing on discovering and developing disruptive therapeutic solutions for serious or incurable diseases.
- Website
- www.kurmapartners.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-23 16:15:20 UTC
- Signal ID
- 2ed421b6-f091-4568-ab9c-d6a3985d6208
As the API returns it
{
"id": "2ed421b6-f091-4568-ab9c-d6a3985d6208",
"created_at": "2026-04-23T16:15:20.896105Z",
"company_name": "Kurma Partners",
"company_website_url": "www.kurmapartners.com",
"company_linkedin_url": "https://www.linkedin.com/company/kurma-life-sciences-partners",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Kurma Partners, a member of Eurazeo Group, announces the final closing of its new Biofund IV for €215 million. The fund has already invested in 11 biotech companies and targets around 20 companies, focusing on discovering and developing disruptive therapeutic solutions for serious or incurable diseases.*"
}